Browse Data and Analysis

On June 28, 2019, the Ministry of Agriculture, Forestry and Fishery (MAFF) published a draft guideline on the Specific Information Disclosure Procedures of Living Organisms Obtained....

On June 27, 2019, the Ministry of Health, Labour and Welfare (MHLW) published a draft of the Handling Procedure of Foods and Food Additives Derived from Genome Editing Technology....

On June 20, 2019, per the request of the Consumer Affairs Agency (CAA), the Consumer Committee in the Cabinet Office of Japan held its second public meeting to discuss the possible creation....

Prime Minister Medvedev Interview on Food Embargo…. Duma Considers Draft Law Tightening Labeling Control of Genetically Engineered Products….

In 2008, El Salvador abolished the Planting Seed Law that required imported seeds to have a phytosanitary certificate with an additional declaration stating that the seeds did not contain GMOs.

Argentina continues to be the third largest producer of biotech crops after the United States and Brazil, producing 14 percent of the world´s total biotech crops.

The Philippines continues to be a regional leader in biotech research and commercialization, as well as a model for science-based and thorough GE regulatory policy.

The German Federal Cartel Office has imposed a fine for sausage price fixing in July 2014.

Since January 2014, the Burkinabe National Biosafety Agency (NBA) has been converting the status of the organization to a technical and scientific public institution (EPSET) for greater autonomy.

Continued interest expressed by farmers and agricultural scientists to improve agricultural output via biotechnology has not resulted in a legal framework for either testing or commercializing biotech

Following a near six month regulatory review, the Vietnam Minister of Agriculture signed the first four Certificates for Food and Feed Safety for four genetically modified corn traits.

Again, this year, Italy’s biotechnology industry is characterized as a dynamic and promising sector, despite the difficult economic situation that biotech companies have to confront on a daily basis.